InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Seidel-Dugan Cynthia, Directeur Scientifique. Insider active across 1 companies, notably Werewolf Therapeutics, Inc.. In total, 2 disclosures have been published. The latest transaction was filed on 12 January 2022 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations2 total
€33,21224,199 shares@ €1.37250.11% mcap100.0% of flow
Common Stock
SEC:0000899243-22-002027·
€33,21224,199 shares@ €1.37250.11% mcap50.0% of flow
Common Stock
SEC:0000899243-22-002027:0·
2 of 2 declarations
About Seidel-Dugan Cynthia
Cynthia Seidel-Dugan is the Chief Scientific Officer at Werewolf Therapeutics, Inc. She oversees research and development activities, ensuring that the company remains at the forefront of innovation in the therapeutic field. Her expertise is crucial for the scientific success of Werewolf Therapeutics.
